ASLAN Pharmaceuticals (ASLN) Competitors $0.60 0.00 (0.00%) As of 03/31/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsTrendsBuy This Stock ASLN vs. PWUP, KZIA, CMND, CPHI, ADIL, APM, CELZ, ALLR, PRTG, and GRIShould you be buying ASLAN Pharmaceuticals stock or one of its competitors? The main competitors of ASLAN Pharmaceuticals include PowerUp Acquisition (PWUP), Kazia Therapeutics (KZIA), Clearmind Medicine (CMND), China Pharma (CPHI), Adial Pharmaceuticals (ADIL), Aptorum Group (APM), Creative Medical Technology (CELZ), Allarity Therapeutics (ALLR), Portage Biotech (PRTG), and GRI Bio (GRI). These companies are all part of the "pharmaceutical products" industry. ASLAN Pharmaceuticals vs. PowerUp Acquisition Kazia Therapeutics Clearmind Medicine China Pharma Adial Pharmaceuticals Aptorum Group Creative Medical Technology Allarity Therapeutics Portage Biotech GRI Bio PowerUp Acquisition (NASDAQ:PWUP) and ASLAN Pharmaceuticals (NASDAQ:ASLN) are both small-cap manufacturing companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, community ranking, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment. Do analysts prefer PWUP or ASLN? ASLAN Pharmaceuticals has a consensus price target of $72.00, suggesting a potential upside of 11,900.00%. Given ASLAN Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe ASLAN Pharmaceuticals is more favorable than PowerUp Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PowerUp Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00ASLAN Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor PWUP or ASLN? In the previous week, PowerUp Acquisition had 1 more articles in the media than ASLAN Pharmaceuticals. MarketBeat recorded 1 mentions for PowerUp Acquisition and 0 mentions for ASLAN Pharmaceuticals. PowerUp Acquisition's average media sentiment score of 0.00 equaled ASLAN Pharmaceuticals'average media sentiment score. Company Overall Sentiment PowerUp Acquisition Neutral ASLAN Pharmaceuticals Neutral Which has stronger valuation & earnings, PWUP or ASLN? PowerUp Acquisition has higher earnings, but lower revenue than ASLAN Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPowerUp AcquisitionN/AN/AN/AN/AN/AASLAN Pharmaceuticals$12M0.10-$44.22M-$21.92-0.03 Is PWUP or ASLN more profitable? PowerUp Acquisition's return on equity of 0.00% beat ASLAN Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets PowerUp AcquisitionN/A N/A N/A ASLAN Pharmaceuticals N/A -8,454.87%-121.60% Which has more volatility and risk, PWUP or ASLN? PowerUp Acquisition has a beta of 0.05, indicating that its share price is 95% less volatile than the S&P 500. Comparatively, ASLAN Pharmaceuticals has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500. Does the MarketBeat Community favor PWUP or ASLN? ASLAN Pharmaceuticals received 200 more outperform votes than PowerUp Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformPowerUp AcquisitionN/AN/AASLAN PharmaceuticalsOutperform Votes20063.49% Underperform Votes11536.51% Do insiders & institutionals believe in PWUP or ASLN? 19.2% of PowerUp Acquisition shares are owned by institutional investors. Comparatively, 58.8% of ASLAN Pharmaceuticals shares are owned by institutional investors. 48.0% of PowerUp Acquisition shares are owned by company insiders. Comparatively, 4.7% of ASLAN Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryASLAN Pharmaceuticals beats PowerUp Acquisition on 7 of the 11 factors compared between the two stocks. Remove Ads Get ASLAN Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ASLN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASLN vs. The Competition Export to ExcelMetricASLAN PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.23M$6.89B$5.63B$7.79BDividend YieldN/A2.81%5.37%4.04%P/E Ratio-0.037.4223.6218.68Price / Sales0.10207.04371.6689.80Price / CashN/A65.6738.1734.64Price / Book-0.096.206.734.12Net Income-$44.22M$142.11M$3.20B$247.10M7 Day PerformanceN/A-7.28%-5.32%-3.82%1 Month PerformanceN/A-10.45%-0.39%-6.61%1 Year Performance-87.51%-12.86%7.89%-1.67% ASLAN Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASLNASLAN PharmaceuticalsN/A$0.60flat$72.00+11,900.0%N/A$1.23M$12M-0.0330PWUPPowerUp AcquisitionN/A$0.63-8.4%N/A-94.2%$4.90MN/A0.00N/AHigh Trading VolumeKZIAKazia Therapeutics2.8058 of 5 stars$0.95-2.6%$11.50+1,110.4%-74.7%$4.79M$2.31M0.0012News CoverageGap UpCMNDClearmind Medicine0.9656 of 5 stars$1.10-1.8%N/A-10.0%$4.69MN/A-0.59N/AShort Interest ↓Gap UpCPHIChina PharmaN/A$0.24+3.1%N/A-28.9%$4.68M$5.54M0.00250Analyst ForecastADILAdial Pharmaceuticals3.0603 of 5 stars$0.71-3.8%$8.00+1,026.8%-52.3%$4.67MN/A-0.2120Upcoming EarningsShort Interest ↓News CoverageGap DownAPMAptorum Group1.7864 of 5 stars$0.90-2.2%N/A-91.1%$4.66M$430,000.000.0030Short Interest ↓CELZCreative Medical Technology1.4031 of 5 stars$2.64-8.3%N/A-58.3%$4.62M$11,000.00-0.695High Trading VolumeALLRAllarity Therapeutics0.6852 of 5 stars$1.00+1.0%N/A-99.5%$4.43MN/A0.0010Upcoming EarningsShort Interest ↓Gap UpHigh Trading VolumePRTGPortage Biotech0.9651 of 5 stars$4.20+1.2%N/A-17.9%$4.41MN/A-0.106Short Interest ↓Gap UpGRIGRI Bio3.0624 of 5 stars$8.06-2.5%$195.50+2,325.6%-98.1%$4.23MN/A-0.701Short Interest ↓News CoverageGap UpTrading Halted Remove Ads Related Companies and Tools Related Companies PWUP Alternatives KZIA Alternatives CMND Alternatives CPHI Alternatives ADIL Alternatives APM Alternatives CELZ Alternatives ALLR Alternatives PRTG Alternatives GRI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASLN) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ASLAN Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share ASLAN Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
